National Granted Programs and Public Funds for Biopharmaceutical Startups in Japan

ABSTRACT In Japan, biopharmaceutical startups have not been sufficiently nurtured, leading to weak international competitiveness in new drug development. This is partly due to low levels of entrepreneurship in the private sector and limited investment in startups. Therefore, it is crucial for the Ja...

Full description

Saved in:
Bibliographic Details
Main Author: Ryo Okuyama
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.70106
Tags: Add Tag
No Tags, Be the first to tag this record!